Patents by Inventor Koichi Ikesue

Koichi Ikesue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8932625
    Abstract: An adhesive patch comprising a substrate and a pressure-sensitive adhesive base, wherein the pressure-sensitive adhesive base comprises a rubbery polymer having double bonds in the main chain and a nonsteroidal anti-inflammatory analgesic and contains a UVA screening agent and/or UVB screening agent as a stabilizer for the rubbery polymer. The adhesive patch is excellent in the stability of the pressure-sensitive adhesive base and in drug infiltration into the skin.
    Type: Grant
    Filed: December 24, 2004
    Date of Patent: January 13, 2015
    Assignee: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Yoshiaki Hashimoto, Yasunori Takada, Miyuki Shinmura, Shigeo Suzuki, Kiyomi Tsuruda, Koichi Ikesue
  • Publication number: 20100311700
    Abstract: A transdermal preparation for external use which contains a photosensitive NSAID and a UV blocker having a high ability to migrate into the skin. Thus, it becomes possible to ensure, in a transdermal preparation for external use containing a NSAID, the inhibition of the onset of light-induced non-immunological or immunological skin symptoms by the above-described component.
    Type: Application
    Filed: April 29, 2010
    Publication date: December 9, 2010
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Kazuhisa Yoshitake, Kenji Atarashi, Tetsuji Kuwahara, Koichi Ikesue, Michinori Sakai, Yoshiaki Hashimoto, Kiyomi Tsuruda
  • Publication number: 20100240758
    Abstract: An external preparation for percutaneous administration which contains a light-sensitive nonsteroidal anti-inflammatory analgesic and a UVA-shielding agent which inhibits the analgesic to cause light toxicity and a light allergy. This external preparation for percutaneous administration, which contains a nonsteroidal anti-inflammatory analgesic, can be prevented, with higher certainty, from causing the hypersensitivity to light attributable to light toxicity and a light allergy.
    Type: Application
    Filed: June 3, 2010
    Publication date: September 23, 2010
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Kazuhisa YOSHITAKE, Kenji ATARASHI, Tetsuji KUWAHARA, Koichi IKESUE, Michinori SAKAI, Yoshiaki HASHIMOTO, Kiyomi TSURUDA
  • Publication number: 20080317689
    Abstract: A transdermal preparation for external use which contains a photosensitive NSAID and a UV blocker having a high ability to migrate into the skin. Thus, it becomes possible to ensure, in a transdermal preparation for external use containing a NSAID, the inhibition of the onset of light-induced non-immunological or immunological skin symptoms by the above-described component.
    Type: Application
    Filed: February 24, 2006
    Publication date: December 25, 2008
    Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
    Inventors: Kazuhisa Yoshitake, Kenji Atarashi, Tetsuji Kuwahara, Koichi Ikesue, Michinori Sakai, Yoshiaki Hashimoto, Kiyomi Tsuruda
  • Publication number: 20070154531
    Abstract: An adhesive patch comprising a substrate and a pressure-sensitive adhesive base, wherein the pressure-sensitive adhesive base comprises a rubbery polymer having double bonds in the main chain and a nonsteroidal anti-inflammatory analgesic and contains a UVA screening agent and/or UVB screening agent as a stabilizer for the rubbery polymer. The adhesive patch is excellent in the stability of the pressure-sensitive adhesive base and in drug infiltration into the skin.
    Type: Application
    Filed: December 24, 2004
    Publication date: July 5, 2007
    Inventors: Yoshiaki Hashimoto, Yasunori Takada, Miyuki Shinmura, Shigeo Suzuki, Kiyomi Tsuruda, Koichi Ikesue
  • Publication number: 20070148216
    Abstract: An external preparation for percutaneous administration which contains a light-sensitive nonsteroidal anti-inflammatory analgesic and a UVA-shielding agent which inhibits the analgesic to cause light toxicity and a light allergy. This external preparation for percutaneous administration, which contains a nonsteroidal anti-inflammatory analgesic, can be prevented, with higher certainty, from causing the hypersensitivity to light attributable to light toxicity and a light allergy.
    Type: Application
    Filed: September 3, 2004
    Publication date: June 28, 2007
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Kazuhisa Yoshitake, Kenji Atarashi, Tetsuji Kuwahara, Koichi Ikesue, Michinori Sakai, Yoshiaki Hashimoto, Kiyomi Tsuruda
  • Publication number: 20060188557
    Abstract: A transdermal formulation for external application comprising a non-steroidal anti-inflammatory analgesic, an alkyl ester of gallic acid, and a phenolic radical scavenger having a branched-chain lower alkyl group. An interleukin-1? production inhibitor consisting of a phenolic radical scavenger having a branched-chain lower alkyl group, and/or an alkyl ester of gallic acid.
    Type: Application
    Filed: May 24, 2004
    Publication date: August 24, 2006
    Applicant: Hisamitsu Pharmaceutical Co., Inc.
    Inventors: Atsutoshi Ikesue, Kazuhisa Yoshitake, Kenji Atarashi, Koichi Ikesue, Michinori Sakai, Amarender Reddy, Yoshiteru Motoki, Dange Veerapaneni